Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Matt Bundenthal is direct sales and communications manager at Fette Compacting America, www.fetteamerica.com .

Articles

Learn how to prevent common causes of product loss.

Optimizing Yields on Modern Tablet Presses

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Robotic fill/finish systems reduce human intervention, improve flexibility, and allow more gentle handling of containers.

Robots Package Parenteral Products

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.

Catalysis, Flow Chemistry Impact API Manufacturing

Catalent combines its formulation expertise, manufacturing excellence and particle size reduction technologies to provide a broad range of solutions in the development of inhalation and nasal drug products.

Manufacturing and Formulation Solutions for Inhaled Dose Forms

Companies believe that biologics and biosimilars would experience the fastest growth over the next year; there is also interest on increasing market penetration of generic drugs.

Growth of Japanese Pharma Market Driven by Biologics and Generic Drugs, Says CPhI Report

Sandoz, a Novartis division, announced  that the Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions recommending the approval of its biosimilars rituximab and  etanercept in Europe, for the same indications as the respective reference medicines.

Sandoz’s Rituximab and Etanercept Biosimilars Recommended for European Approval

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Although technical paths for continuous solid-dosage manufacturing have been laid out and equipment and control systems have been developed, industry is slow to move forward.

Paving the Way for Continuous Manufacturing

The funding allows the company to broaden its range of services and finance its move to new laboratory facilities in the Illkirch-Graffenstaden innovation park in northeast France.

Inoviem Scientific Secures Funding to Finance Expansion

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Pharmaceutical Technology spoke with CPhI North America presenter Jonathan Helfgott to discuss navigating GDUFA and helpful tips for submitting successful ANDAs.

Former CDER OSI Associate Director for Risk Science to Speak at CPhI North America 2017

The project will foster the translation of nanomedicine applications for the treatment of cardiovascular diseases.